James Zacny to Drug Administration Schedule
This is a "connection" page, showing publications James Zacny has written about Drug Administration Schedule.
Connection Strength
0.092
-
Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther. 2005 Jun 01; 21(11):1299-312.
Score: 0.055
-
Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors. Am J Clin Oncol. 2019 05; 42(5):413-420.
Score: 0.036